Healthcare
Synergy CHC Corp.(SNYR)
Live Price
Offline$0.196
-2.97% today
1Y Change
-91.88%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- โ
- Revenue Growth
- -12.8%
- EPS Growth
- -553.6%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Synergy CHC Corp. (SNYR) is a Healthcare stock with listed on NASDAQ. The stock last traded around $0.20 and down 91.9% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -12.8%, EPS growth of -553.6%, a dividend yield of 0.0%. What stands out right now is revenue -12.8%, EPS -553.6%, free cash flow +46.2% with operating margin -5.9% and ROIC -48.8%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SNYR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-12.8% vs +7.6% peer median
Operating Margin
Below sector median
-5.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 21, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -12.8% and EPS is at -553.6%, with operating margin around -5.9%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 6, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -8.7% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 21, 2026 | โ | +2.0% | +7.6% | โ |
2026 Apr 1, 2026 | -13600.0% | -21.6% | -39.8% | -69.4% |
2025 Nov 13, 2025 | +0.0% | +5.3% | +6.0% | -8.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNYR
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SNYR Max Drawdown
-95.29%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SNYR and SPY.
Company Overview
Synergy CHC Corp.
NASDAQ Capital Market
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was incorporated in 2010 and is based in Westbrook, Maine.
- Leadership
- Jack Ross
- IPO Date
- Mar 17, 2014
- Employees
- 21
- Street Address
- 865 Spring Street
- Mailing
- Westbrook, ME, 04092
- Region
- Westbrook, ME, US
- Reporting Currency
- USD
- Investor Line
- 615 939 9004
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.1
- Price/Book
- โ
Growth
- Revenue
- -12.8%
- EPS
- -553.6%
- Free Cash Flow
- +46.2%
Profitability
- Gross Margin
- 66.7%
- Operating Margin
- -5.9%
- Net Margin
- -40.6%
- ROE
- 83.1%
- ROIC
- -48.8%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 1.22
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.